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Abstract
Background: The gap between evidence-based guidelines for clinical care and their use in medical settings is well
recognized and widespread. Only a few implementation studies of psychiatric guidelines have been carried out,
and there is a lack of studies on their long-term effects.
The aim of this study was to measure compliance to clinical guidelines for treatment of patients with depression
and patients with suicidal behaviours, two years after an actively supported implementation.
Methods: Six psychiatric clinics in Stockholm, Sweden, participated in an implementation of the guidelines. The
guidelines were actively implemented at four of them, and the other two only received the guidelines and served
as controls. The implementation activities included local implementation teams, seminars, regular feedback, and
academic outreach visits. Compliance to guidelines was measured using quality indicators derived from the
guidelines. At baseline, measurements of quality indicators, part of the guidelines, were abstracted from medical
records in order to analyze the gap between clinical guidelines and current practice. On the basis of this, a series
of seminars was conducted to introduce the guidelines according to local needs. Local multidisciplinary teams
were established to monitor the process. Data collection took place after 6, 12, and 24 months and a total of 2,165
patient records were included in the study.
Results: The documentation of the quality indicators improved from baseline in the four clinics with an active
implementation, whereas there were no changes, or a decline, in the two control clinics. The increase was
recorded at six months, and persisted over 12 and 24 months.
Conclusions: Compliance to the guidelines increased after active implementation and was sustained over the two-
year follow-up. These results indicate that active local implementation of clinical guidelines involving clinicians can
change behaviour and maintain compliance.
Background
Transferring research results into routine clinical prac-
tice is complicated; several studies have described imple-
mentation difficulties and the complexity of achieving
performance change in health care [1,2]. Single interven-
tions are not effective solutions [3,4]. Although knowl-
edge about effective implementation strategies has
increased their use, it has mostly only resulted in small
to moderate improvements. Clinical practice guidelines
are defined as ‘systematically developed statements to
assist practitioner and patient decisions about appropri-
ate healthcare for specific clinical circumstances’ [5].
Clinical guidelines can be used as tools [6-8], but a
passive dissemination alone has rarely been effective in
changing health care professionals’ behaviour [1,9].
Guidelines have modest influence on clinical practice
unless they are successfully integrated into the clinical
settings [10]. Guidelines aim to influence the treatment
behaviour of practitioners. However, studies are needed
to show that physicians exposed to guidelines provide
better treatment [11].
There is a gap between evidence-based knowledge and
current practice in many medical areas [9,12], and how
best to implement guidelines into routine care remains
unclear [13]. Implementation of guidelines mostly
entails complex interventions, and effective interventions
are often elaborated in complicated procedures [14,15].
Commonly evaluated multifaceted implementation * Correspondence: tord.forsner@ki.se
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cational outreach [2].
Successful implementation is not enough; there is also
a need for continuous follow-up both of compliance to
the guidelines and whether it is maintained over time.
There are numerous studies showing that compliance
returned to baseline after implementation of clinical
guidelines [16]. So far, little has been accomplished
regarding strategies for maintaining compliance. Objec-
tive measures are needed, e.g., quality indicators. Ideally,
these should be derived from clinical guidelines that are
based on scientific research or consensus among
experts. These indicators should be measures of process
and thus also measure quality of care [17]. Numerous
indicators have been developed to evaluate and assess
the care provided to patients with chronic physical ill-
nesses [18], but there is lack of studies of care provided
to patients with psychiatric disorders [19]. In addition,
we have not found long-term follow-up studies in psy-
chiatry on whether changes in practice after guidelines’
implementation are sustained.
This study aimed to assess the effects at 12 and 24
months of an implementation intervention designed to
improve documentation of quality indicators in accor-
dance with clinical guidelines for treatment of depres-
sion and suicidal behaviour in patients at six clinics in
Stockholm, Sweden.
Methods
Implementation of psychiatric guidelines in Stockholm
In Stockholm county, Sweden, a series of regional clini-
cal guidelines regarding psychiatric disorders has been
published and disseminated since 2002 [20,21]. Provi-
ders and purchasers in collaboration with Stockholm
Medical Advisory Board run the development work. The
intention is to require the clinical guidelines to be
implemented in all psychiatric clinics in the county in
order to provide high quality care on equal terms for all
of the county’s citizens [20,21]. A pilot study has been
conducted on the implementation of clinical guidelines
in the care of depression and suicide. Quality indicators
derived from the clinical guidelines were used to study
compliance. Our previous study showed that the indica-
tors were feasible for audit and feedback as part of the
implementation strategy, and a six-month follow-up
showed favourable changes in clinical practice [22].
Settings and participating clinics
In the present study, clinical guidelines for assessment
and treatment of depression and guidelines for assess-
ment and treatment of patient with suicidal behaviours
were implemented in six psychiatric clinics in Stock-
holm, Sweden. In Stockholm, treatment is provided
almost exclusively by clinics in the public sector. All six
psychiatric departments in Stockholm County were
invited to implement the guidelines, and four depart-
ments decided to participate. Six general psychiatric
clinics for adults were included; all were outpatient
clinics in an urban area. The resources and organization
were comparable. The two departments that declined
participation did not differ from the ones that accepted
participation in terms of organization of care, personnel
resources, and population, as they had uniform con-
tracts with the county council purchasing office. Six
clinics in the four departments were randomly selected,
and they were randomly assigned to an intervention
group or a control group. Two of these clinics partici-
pated in implementing the clinical guidelines for depres-
sion, and two clinics in implementing the clinical
guidelines for suicidal behaviours. Two clinics received
the guidelines, but were not included in the intervention
and acted as controls.
Implementation process at the intervention clinics
The study began in May 2003. The first author and an
external psychiatrist supported the implementation pro-
cess during the first six months. Local multidisciplinary
teams, co-led by the external psychiatrist, including
nurses, physicians, counsellors, and psychologists were
established at each of the four active clinics. The teams
were locally elected and participation in the local imple-
mentation work and meetings was voluntary. The first
author presented the implementation study and the
quality indicators for each team.
Implementation started with a baseline collection of
quality indicators from medical records in order to ana-
lyze the gap between clinical guidelines and current
local practice. On the basis of this, a series of seminars
was conducted to introduce the guidelines according to
the identified needs. The implementation teams learned
to use strategies for improvements, e.g., following a
cyclical process of change (plan-do-study-act model)
approach [23], which was used to change local practices.
Regular meetings then took place and the leaders of the
teams promoted the value of implementation activities
regarding patient sessions and clinical behaviour. At the
meetings, all members of staff were involved in setting
local goals for implementation based on the quality indi-
cators. They were also encouraged to provide feedback
and identify potential barriers and promoters to change.
Feedback was given every month, based on the indicator
scores, in order to ensure that improvements were gra-
dually achieved and maintained. Local workshops at the
clinics were conducted weekly during the study period,
in which participants met to exchange useful
approaches.
The active implementation strategies were based on
organizational learning theory and previous knowledge
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learning organisation is described as a process of
increasing the capacity for effective organisational action
through knowledge and understanding [24]. Through
the learning of individuals, the organisational routines
are changed. One member of the research team (first
author) performed site visits (academic outreach detail-
ing) every month to the intervention clinics during the
implementation period. Regular discussions of ‘best
practice’ were held. Through facilitation, practitioners
were helped to formulate and reflect on their practical
knowledge and professional behaviour. Members of the
local implementation teams participated twice in a
regional network in order to enhance effective imple-
mentation strategies and experience during the study.
The participants were encouraged to contact others in
the network to exchange experiences and inspiration in
the implementation work. During implementation, the
adaptation of care defined by clinical guidelines was
conducted by the implementation teams. A protocol for
local use was developed to promote the adaptation of
best practice, based on the clinical guidelines. A sum-
mary of the performed interventions is presented in Fig-
ure 1.
Data collection
The data collection took place before the start of the
study, and after 6, 12, and 24 months. Patient records
from adult men and women with an ICD-10 or DSM-IV
diagnosis of depression were eligible for inclusion in the
study on the implementation of the clinical guidelines
for depression. For the implementation of the clinical
guidelines for suicide attempters, the inclusion criteria
were patient records from adult men and women
appraised at psychiatric emergency clinics after a suicide
attempt. The first 120 medical records that fulfilled the
inclusion criteria from specific dates were randomly
selected from each clinic, identified through the admin-
istration system. This was repeated at 6, 12, and 24
months. For the data collection before implementation,
60 to 61 records were collected from each clinic. At the
control clinics, 120 medical records were selected before
implementation and 120 records at each data collection
point during the follow-up period. Trained abstractors
examined the medical records. Inter-rater reliability was
assessed by a random replicate sample of 40 records.
(Kappa 0.92 to 1.0). The study was approved by The
Central Ethical Review Board at Karolinska Institutet.
Study population
A total of 2,165 patient records were included in the
systematic assessment. The study of the implementation
of the clinical guidelines for depression included 1,083
adult patients, mean age 36.3 years (SD 11.2) diagnosed
with a depression according to ICD-10 or DSM-IV
[25,26]. There were no differences between the imple-
mentation and control clinics regarding gender and age
distribution of the included patients. The study of the
implementation of the clinical guidelines for suicidal
behaviours included 1,082 adult patients, mean age 35.1
years (SD 14.7) At baseline, the mean age of the patients
at the implementation clinics was lower (32.5 (12.2),
versus 38.3(15.2), t = 2.8, p < 0.01) but there were no
gender differences. At six months, there were no age or
gender differences.
At 12 and 24 months there were more females and
younger patients at the implementation clinics (74.6%
versus 64.2%, Chi-square = 4.2, p < 0.1) (mean age 33.7
(13.2) versus 40.4(19.0), t = 3.9, p < 0.001), (70.0% ver-
sus 52.5%, Chi-square = 10.7, p < 0.001)(mean age 33.3
(13.4) versus 37.8(16.7), t = 2.7, p < 0.01).
Selection of quality indicators
Process indicators extracted from the clinical guidelines
were used as indicators of compliance. A modified audit
instrument by Gardulf and Nordström [27] was used to
assess the presence of the quality indicators. Each indi-
cator was rated on a assessment scale from zero to two.
T h ep r e s e n c eo ft h eq u a l i t yi ndicators in the medical
records was given a score from zero to two, (zero,
recommended criteria to guidelines were not met; one,
recommended criteria were partially met according to
the definition; and two, a clear occurrence). In a subse-
quent analyses, we used the quality indicators a binary
variables where one and two (i.e., partial or full adjust-
ment to the recommendation) were compared to zero (i.
e., no adjustment to the recommendation). As a sensitiv-
ity analysis, quality indicators were also categorised as
t w ov e r s u sz e r oa n do n e .W eh a v ef o u n de s s e n t i a l l y
similar results with this alternative approach (data not
shown). For all indicators, higher scores were desirable
and indicated a better compliance to the guidelines. The
indicators also were summarised to a total score for
each clinical guideline. The total score for the guidelines
for treatment of depression was 22 points and 26 points
for the guidelines for suicidal behaviour. Special record-
ing forms were developed for the data collection. Qual-
ity indicators for implementation of the clinical
guidelines for the care of persons affected by depression
and clinical guidelines for suicidal patients are listed in
Table 1.
Statistical analysis
T h ed a t aw e r ea n a l y s e du s i n gS T A T Aa n dS P S Sf o r
Windows, versions 10 and 16.0, respectively. Inter-rater
reliability was analysed by calculating Cohen’sK a p p a .
Differences regarding age and gender distribution of the
included patient records at implementation and control
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To address the nested structure of our data, we fitted
random-effects logit models where we clustered patients
within their health care providers using ‘xtlogit’ com-
mand in STATA [28]. Odds ratios were calculated for
the dichotomized quality indicators comparing quality
of care before (reference category) and after 6, 12, and
24 months, respectively.
Results
Compliance to the clinical guidelines for depression
Table 2 shows compliance at baseline, and 6, 12, and 24
months after implementation of clinical guidelines for
depression, based on the quality indicators. The docu-
mentation of the quality indicators improved from the
baseline in the four clinics where implementation was
carried out, whereas there were no changes, or a decline,
in the documentation of most quality indicators in those
without implementation. For most of the quality indica-
tors, the increase was recorded at six months and
persisted over 12 and 24 months. Although, for a few
quality indicators the 24-month follow-up audit showed
a slight decrease compare to the measurement at 12
months.
The compliance for some indicators was low initially
and after implementation showed considerable improve-
ment, e.g., the compliance for structured suicide assess-
ment rose from 40.2% (for a clear occurrence to
guidelines) before implementation to at least 97.5% after
(Table 2). Total score of the quality indicators for clini-
cal guidelines for depression with 95% confidence inter-
val are presented in Figure 2.
Compliance to the clinical guidelines for the management
of suicide attempters
A similar pattern was seen in the documentation of the
quality indicators in the clinics that implemented the
clinical guidelines for suicide attempters. There was an
increase of the documentation at six months, and the
increase persisted over 12 and 24 months (Table 3).
Figure 1 A summary of the performed implementation interventions.
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structured suicide assessment for suicidal patients rose
from 55.4% to 97.1% for a partial or clear occurrence of
g u i d e l i n e sa n ds p e c i a l i s ta s s e s s m e n tr o s ef r o m5 0 . 4 %t o
91.7%. Figure 2 shows the total score of the quality indi-
cators for clinical guidelines for suicidal behaviours with
a 95% confidence interval.
Discussion
This paper describes an actively supported implementa-
tion of clinical guidelines in psychiatric settings and
examined compliance before implementation and after
6, 12, and 24 months using quality indicators as mea-
surements. The results showed that there was a consis-
tent significant increase in the documentation of almost
all of the quality indicators, that this occurred after a
rather short period of time, and was sustained at almost
the same level throughout the two-year study period.
The increase was only observed in the intervention
clinics and not at the clinics to which the guidelines
were only disseminated. These findings imply that a sys-
tematic implementation approach gives sustainable
Table 1 Quality indicators for evaluation of quality of care in depression treatment and care after a suicide attempt.
Indicator Definition Requirements
Accessibility/wait
time
The time between referral and actual contact with mental health
service
Patients receive an assessment from a mental health
specialist within three weeks of their first visit to the
outpatient clinic. Patients with depression and suicidal
thoughts offered first contact (appointment) within 24 hours.
Diagnostic
assessment
Documentation of present depression symptoms. The medical
record should document at least three of nine DSM-IV target
symptoms for major depression.
Depression symptoms (such as decreased socialization, sleep
disorders, poor appetite according DSM-IV) noted in the
medical record.
Standardized
rating scale
Clinical depression assessment that includes a standardized
rating scale.
Monitoring signs and symptoms of depression using a
validated standardized rating scale at the first visit. Scale and
total sum documented in the medical record. Suggestions
of scales to be used were presented in the guidelines.
Diagnostic
instrument
Diagnostic structured interview A semi-structured diagnostic interview e.g., SCID or M.I.N.I
performed. Completed before the third visit.
Standardized
rating scale during
treatment
Standardized rating scale during treatment for assessment of
symptoms and behaviour.
Standardized rating scale performed within two weeks.
Monitoring signs and symptoms of depression using
standardized rating scale during treatment. Adjusted
interventions if signs and symptoms are still present,
presented in the guidelines.
Substance, drug
abuse
Screening for substance use disorder. Asked for current substance use and evaluated for the
presence and/or history of substance use disorder.
Screenings instruments such as AUDIT. Motivation interview
conducted e.g., CAGE method.
Treatment plan
(care plan)
A written treatment plan documented and individually tailored
for the patient
The treatment plan should include; treatment, goals, time
for evaluation and drawn up together with the patient.
Evaluation/
Outcome
Has patient responded to antidepressant? Achieved symptom
remission or reduction between admission and follow-up?
Documented response to treatment within expected
treatment frame and monitored progress. Completed a
comprehensive evaluation of symptoms.
Continuity Ability to provide uninterrupted care over time. Continuity offered to the patient, same caregiver during
treatment. Defined as less than two different caregivers.
Suicide assessment A structured assessment documented in the medical record
using standardized rating scale.
Identified suicidal thoughts, plans and symptoms,
documented and evaluated in the medical record. Re-screen
and assessment performed at every visit and documented in
the medical record.
Antidepressant
medication
Current treatment with an antidepressant medication for patients
with major depressive disorder, moderate or severe.
Begin appropriate antidepressant medication according the
guidelines. Started within two visits.
Specialist
assessment after
suicide attempt
Assessment by a senior physician within 24 hours after a suicide
attempt
A senior mental health specialist has made the assessment
within 24 hours.
Suicide assessment A structured assessment documented in the medical record
using standardized rating scales.
Identified suicidal thoughts, plans and symptoms,
documented and evaluated in the medical record.
Depression assessment conducted using standardized rating
scale.
Follow-up Care plan formulated and documented. Documented discharge plans. Referral to a psychiatric
outpatient clinic
Evaluation Documented assessment after discharge. Should have a follow-up visit with a mental health specialist
within one week after assessment or discharge. Telephone
contact with patient during this period.
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% (n).
Implementation clinics Control clinics
Indicator % (n) OR (95% CI) % (n) OR (95% CI)
Accessibility/wait time
0 months 77.9 (95) reference 59.0 (36) reference
6 months 89.2 (107) 2.4 (1.1-5.2) 53.3 (32) 0.6 (0.3-1.4)
12 months 97.1 (233) 13.4 (5.3-34.0) 44.2 (53) 0.4 (0.2-0.9)
24 months 90.0 (216) 2.5 (1.3-4.9) 51.7 (62) 0.6 (0.3-1.2)
Diagnostic assessment
0 months 83.6 (102) reference 88.5 (54) reference
6 months 97.5 (117) 9.6 (2.5-36.1) 90.0 (54) 1.1 (0.4-3.6)
12 months 97.5 (234) 11.1 (4.0-30.9) 83.3 (100) 0.6 (0.3-1.6)
24 months 97.9 (235) 10.9 (3.7-32.4) 79.2 (95) 0.5 (0.2-1.2)
Diagnostic instrument
0 months 12.3 (15) reference 1.6 (1) reference
6 months 28.3 (34) 2.8 (1.4-5.5) 0 na
12 months 41.3 (99) 5.3 (2.9-9.7) 0.8 (1) na
24 months 44.2 (106) 5.7 (3.1-10.5) 0.8 (1) na
Standardized rating scale
0 months 64.8 (79) reference 44.3 (27) reference
6 months 91.7 (110) 6.2 (2.9-13.3) 33.3 (20) 0.7 (0.3-1.4)
12 months 95.0 (228) 11.1 (5.5-22.3) 37.5 (45) 0.8 (0.4-1.5)
24 months 94.2 (226) 9.1 (4.7-17.6) 36.7 (44) 0.7 (0.4-1.4)
Standardized rating scale during treatment
0 months 50.0 (61) reference 24.6 (15) reference
6 months 87.5 (105) 7.6 (3.9-14.9) 38.3 (23) 1.9 (0.8-4.2)
12 months 97.5 (234) 47.5 (19.0-118.2) 30.8 (37) 1.4 (0.7-2.8)
24 months 88.3 (212) 8.1 (4.7-14.3) 33.3 (40) 1.5 (0.8-3.1)
Substance/drug abuse
0 months 46.7 (57) reference 32.8 (20) reference
6 months 87.5 (105) 8.0 (4.2-15.4) 53.2 (32) 2.8 (1.3-6.2)
12 months 94.2 (226) 18.5 (9.7-35.4) 35.0 (42) 1.2 (0.6-2.3)
24 months 88.8 (213) 9.1 (5.3-15.6) 43.3 (52) 1.8 (0.9-3.6)
Treatment (care) plan
0 months 59.8 (73) reference 42.6 (26) reference
6 months 87.5 (105) 5.5 (2.7-11.1) 38.3 (23) 0.9(0.4-1.9)
12 months 90.4 (217) 8.4 (4.5-15.5) 34.2 (41) 0.7 (0.4-1.4)
24 months 91.3 (219) 8.1 (4.3-15.0) 27.5 (33) 0.5 (0.3-1.0)
Evaluation/outcome
0 months 66.4 (81) reference 59.0 (36) reference
6 months 95.8 (115) 11.9 (4.5-31.7) 55.0 (33) 0.8 (0.4-1.7)
12 months 97.5 (234) 20.3 (8.2-49.9) 48.3 (58) 0.6 (0.3-1.1)
24 months 95.8 (230) 11.9 (5.7-25.0) 48.3 (58) 0.6 (0.3-1.1)
Continuity
0 months 77.0 (94) reference 78.7 (48) reference
6 months 95.0 (114) 5.6 (2.2-14.1) 61.7 (37) 0.4 (0.2-1.1)
12 months 99.6 (239) 72.0 (9.7-537.4) 71.7 (86) 0.7 (0.3-1.5)
24 months 95.8 (230) 6.7 (3.1-14.4) 68.3 (82) 0.6 (0.3-1.4)
Suicide assessment
0 months 40.2 (49) reference 45.9 (28) reference
6 months 95.8 (115) 36.1 (13.5-96.5) 35.0 (21) 0.6 (0.3-1.4)
12 months 93.8 (225) 23.3 (12.1-44.7) 35.8 (43) 0.7 (0.4-1.2)
24 months 97.5 (234) 61.3 (24.8-151.9) 30.0 (36) 0.5 (0.3-1.0)
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by quality indicators. Our study describes the challenge
implicit in real-world implementation aimed at improv-
ing the quality of care. The aim of all implementation is
a change that remains after the support is withdrawn,
and the results indicate that changes had taken place in
the organization and structu r eo ft h ec a r ep r o v i d e da t
the implementation clinics. In order to achieve these
changes, an active implementation was needed and not
just a dissemination of, or lecturing about, guidelines.
This finding is in accord with earlier studies [11,29,30].
It could be assumed that the current clinical practice
was close to recommended care as presented in the
guidelines, because the latter were based on information
easily available to all clinicians. However, we found that
there were large gaps between current clinical practice
and recommended practice according to guidelines,
especially in the clinics where guidelines for suicidal
patients were implemented. The implementation
required complex changes in clinical practice, better col-
laboration, and changes in the organization of care.
T h e r ea r es e v e r a ll i k e l ye x p l a n a t i o n sf o rt h eo b s e r v e d
improvements. First, local implementation teams with
multidisciplinary members were established. This initia-
tive was intended to develop collaboration for organiza-
tional learning of best practice and change of clinical
practice. The teams were encouraged to involve all staff
at the clinic in adapting the guidelines for local use.
Using local teams facilitated collaborative partnerships,
integrated knowledge, and action. Thus, the team mem-
bers gained a deeper understanding of the context and
challenges of the local health service.
Figure 2 Total score of quality indicators for clinical guidelines for depression and suicide.
Table 2: The compliance before, 6, 12, and 24 months after the implementation of clinical guidelines for depression in
% (n). (Continued)
Antidepressant medication
0 months 54.1 (66) reference 45.9 (28) reference
6 months 90.8 (109) 8.3 (4.1-17.0) 36.7 (22) 0.7 (0.3-1.4)
12 months 85.4 (205) 5.0 (3.0-8.2) 44.2 (53) 1.0 (0.5-1.7)
24 months 92.5 (222) 10.3 (5.7-18.8) 41.7 (50) 0.8 (0.4-1.5)
na The numbers did not allow calculations.
Odds ratios adjusted for age and gender with baseline as the reference is presented with CI (95%)
Forsner et al. Implementation Science 2010, 5:4
http://www.implementationscience.com/content/5/1/4
Page 7 of 11Table 3 The compliance before, 6, 12, and 24 months after the implementation of clinical guidelines for suicidal
behaviour in % (n).
Implementation clinics Control clinics
Indicator % (n) OR (95% CI) % (n) OR (95% CI)
Accessibility/wait time
0 months 15.7 (19) reference 29.5 (18) reference
6 months 14.2 (17) 0.9 (0.4-1.8) 31.7 (19) 1.1 (0.5-2.4)
12 months 70.4 (169) 13.7 (7.7-24.4) 0 na
24 months 59.2 (142) 8.3 (4.7-14.6) 0 na
Diagnostic assessment
0 months 49.6 (60) reference 26.2 (16) reference
6 months 73.3 (88) 2.9 (1.7-5.0) 16.7 (10) 0.6 (0.2-1.5)
12 months 83.3 (200) 5.4 (3.2-8.9) 0.8 (1) 0 (0.0-0.2)
24 months 91.7 (220) 11.8 (6.5-21.2) 0 na
Diagnostic instrument
0 months 0 reference 0 reference
6 months 7.5 (9) na 0 na
12 months 0 na 0 na
24 months 7.5 (18) na 0 na
Standardized rating scale
0 months 41.3 (50) reference 27.9 (17) reference
6 months 67.5 (81) 3.0 (1.7-5.0) 16.7 (10) 0.5 (0.2-1.4)
12 months 79.2 (190) 5.5 (3.4-8.9) 0 na
24 months 78.3 (188) 5.2 (3.2-8.4) 0.8 (1) 0.0 (0.0-0.2)
Standardized rating scale during treatment
0 months 16.5 (20) reference 16.4 (10) reference
6 months 52.5 (63) 5.8 (3.2-10.5) 10.0 (6) 0.6 (0.2-1.7)
12 months 22.9 (55) 1.6 (0.9-2.7) 0.8 (1) 0.04 (0.02-0.35)
24 months 55.8 (134) 6.6 (3.8-11.3) 5.0 (6) 0.3 (0.1-0.9)
Substance/drug abuse
0 months 52.1 (63) reference 55.7 (34) reference
6 months 64.2 (77) 1.7 (1.0-2.9) 56.7 (34) 1.0 (0.5-2.1)
12 months 77.5 (186) 3.4 (2.1-5.5) 25.0 (30) 0.3 (0.2-0.5)
24 months 80.0 (192) 3.8 (2.4-6.2) 29.2 (35) 0.3 (0.1-0.6)
Treatment (care) plan
0 months 37.4 (68) reference 44.3 (27) reference
6 months 58.9 (106) 4.4 (2.5-7.6) 41.7 (25) 0.9 (0.4-1.9)
12 months 67.1 (161) 4.4 (2.7-7.1) 0.8 (1) 0.0 (0.0-0.1)
24 months 79.2 (190) 8.0 (4.9-13.3) 0.8 (1) 0.0 (0.0-0.1)
Evaluation/outcome
0 months 20.7 (25) Reference 19.7 (12) reference
6 months 47.5 (57) 3.5 (2.0-6.2) 8.3 (5) 0.4 (0.1-1.2)
12 months 25.8 (62) 1.3 (0.8-2.3) 0 na
24 months 51.7 (124) 4.1 (2.5-6.9) 0 na
Continuity
0 months 86.0 (104) reference 49.2 (30) reference
6 months 81.7 (98) 0.7 (0.4-1.5) 31.7 (19) 0.5 (0.2-1.1)
12 months 96.3 (231) 4.2 (1.8-9.9) 0 na
24 months 91.3 (219) 1.7 (0.9-3.5) 0 na
Suicide assessment
0 months 55.4 (67) reference 82.0 (50) reference
6 months 93.3 (112) 13.6 (5.9-31.5) 73.3 (44) 0.6 (0.2-1.4)
12 months 87.1 (209) 6.1 (3.5-10.6) 50.0 (60) 0.2 (0.1-0.5)
24 months 97.1 (233) 33.6 (14.1-80.2) 56.7 (68) 0.3 (0.1-0.6)
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Page 8 of 11Further, the interventions included audits and regular
feedback, which helped the local teams to monitor the
implementation. The aim was that the local teams
w o u l db ea b l et oc h o o s et h em o s ti m p o r t a n ta r e a sf o r
intervention and to measure success in terms of
improved compliance to the guidelines and outcomes.
Previous studies have reported that this enhances learn-
ing and facilitate translation of insight to daily work
[31,32]. The organization should make use of the change
process to implement changes of proven effectiveness
regarding implementations strategies.
The feedback was based on quality indicators that
were easy to use and showed a high inter-reliability. The
indicators were all process indicators that had previously
been the subject of discussion as to how to use them
more effectively in mental health care, and they were
not particularly controversial [33]. Furthermore, the
changes are unlikely to be sustained if implementation
does not include repeated measurements to access
advancement and encourage modifications.
Another active strategy was that an outside researcher
made regular visits to support the local teams. Moreover,
all involved teams were part of a regional network that
held regular meetings, because successful adoption of
innovations often depends on interpersonal relationships
within a system or an organization. An organization that
supports knowledge sharing, and encourages observation
and reflections is more successful at innovation and diffu-
sion [34]. The network, as well as the visits, facilitated this.
Although the teams worked locally, they were able to
learn about organizational culture, implementation techni-
que, and improvement models from colleagues in the
regional network. Moreover, this supported the involved
practitioners in analyzing, reflecting upon, and changing
their own attitudes and behaviours. The goal was to trans-
fer implementation technology into the participating orga-
nizations in order to continuously improve each
organization’s capacity for change.
Another critical issue for success of a diffusion of
innovation strategy is leadership [35]. Leadership is
described as an important factor in translating guide-
lines into clinical practice. Lack of support from leader-
ship is identified as one of the greatest barriers [36].
According to Garside [37], leaders must continually
show the desired direction of change, and support the
staff in their new roles and new skills in a change of
organisation or process. In the present study, the leader-
s h i pw a si n v o l v e da ta ni n i t i a lm e e t i n ga tw h i c ht h e
guidelines were presented. Because they had all volun-
teered to participate, they supported the implementation
activities and created a culture in which the changes in
clinical practice were possible.
Thus, a multifaceted intervention including a variety
of active strategies was used [3], which previously has
been reported to be more effective than passive strate-
gies or just the use of feed-back or audit [38]. Shortell
et al. [39] have suggested that five dimensions are
needed for a successful implementation, i.e., process,
strategic, cultural, technical, and structural. Our imple-
mentation program included all of these dimensions.
The standard of care is not the same as the quality of
care. The quality of care provided by the clinician may
be below, equal to, or even above the acceptable stan-
dard of care. Practice parameters are strategies for
patient management, designed to assist health care pro-
fessionals in clinical decision-making. The practice
Table 3: The compliance before, 6, 12, and 24 months after the implementation of clinical guidelines for suicidal
behaviour in % (n). (Continued)
Specialist assessment
0 months 50.4 (61) reference 83.6 (51) reference
6 months 85.4 (103) 6.5 (3.4-12.3) 83.3 (50) 1.0 (0.4-2.6)
12 months 87.5 (210) 7.5 (4.4-12.9) 86.7 104) 1.3 (0.5-3.0)
24 months 91.7 (220) 11.8 (6.5-21.5) 71.7 (86) 0.5 (0.2-1.1)
Follow-up
0 months 72.7 (88) reference 75.4 (46) reference
6 months 88.3 (106) 2.9 (1.5-5.8) 65.0 (39) 0.6 (0.3-1.4)
12 months 86.3 (207) 2.4 (1.4-4.1) 34.2 (41) 0.2 (0.1-0.3)
24 months 92.1 (221) 4.5 (2.4-8.3) 37.5 (45) 0.2 (0.1-0.4)
Evaluation assessment
0 months 32.2 (39) reference 18.0 (11) reference
6 months 64.2 (77) 4.0 (2.3-6.9) 13.3 (8) 0.6 (0.2-1.6)
12 months 63.8 (153) 3.8 (2.4-6.1) 6.7 (8) 0.3 (0.1-0.8)
24 months 75.0 (180) 6.8 (4.2-11.2) 10.8 (13) 0.4 (0.2-1.1)
Odds ratios adjusted for age and gender with baseline as the reference is presented with CI (95%)
na The numbers did not allow calculations.
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Page 9 of 11parameters describe the generally accepted practices, but
are not intended to define a standard of care. The inten-
tions with the quality indicators as presented in the clin-
ical guidelines were to represent ideal practice. Thus,
they could be used to measure deficiencies between cur-
rent practice and ideal practice as defined in the guide-
lines, which would indicate an area for intervention.
These practice parameters reflect the state of knowledge
at the time of development of the guidelines, and most
certainly need to be regularly updated.
Psychiatric disorders are of great importance in public
health. Depression is now the fourth-leading cause of
the global disease burden and the leading cause of dis-
ability worldwide. Depression is the most important risk
factor for suicide, which is among the top three causes
of death in young people ages 15 to 35 [40]. Depression
seriously reduces the quality of life for individuals and
their families, and often aggravates the outcome of other
physical health problems. Because depression is highly
treatable, and currently undertreated, it is an appropri-
ate focus for improvement of the treatment by imple-
menting available evidenced-based clinical guidelines.
Guideline implementation studies in the care of psychia-
tric disorders are lacking, but a review by Weingartner
of clinical guidelines in chronic medical diseases has
stressed the importance of multifaceted interventions
[41]. A comparable conclusion that multiple strategies
seem to be most effective is presented in a systematic
meta-review by Francke [16].
T h e r ew e r es o m el i m i t a t i o n si nt h ep r e s e n ts t u d y .
Firstly, although both intervention and control clinics
were randomly assigned, all had volunteered to partici-
pate, and therefore probably were more motivated to
change. Secondly, given the fact that clinical practice
change is a complex phenomenon dependent on local
context, results from one particular setting can be gen-
eralised only with great caution [42].
Our study had a cluster design where patients were
nested within their health care providers, and the health
care providers were nested within their clinics. While
the clustering at the provider level was properly
addressed in our analyses, due to the low number of
participating clinics it was not possible to fit a three-
level model. Therefore, we could not investigate the pos-
sible role of clinic level covariates, and the lack of con-
trolling for autocorrelation within clinics might inflate
somewhat the standard error of our estimates.
Addressing local needs when implementing clinical
guidelines is important in closing the gap between
research and practice. The need to adapt implementation
efforts to local circumstances has been shown to be valu-
able [43]. Adequate funding is needed to train the staff in
the intervention techniques, establish protocols, and sup-
port evaluation of the outcome. Further research is
needed on practical frameworks to facilitate the imple-
mentation of intervention in mental health care settings.
A large number of factors determine whether or not
implementation will be successful and all factors cannot
be addressed within one theory or model of change.
Further studies are needed to examine our implementa-
tion approach with reference to theories about the
implementation of change. The strength of the present
study is that it is, to our knowledge, the first one to
assess the long-term effects of implementation of psy-
chiatric guidelines.
Conclusions
This study suggested that the compliance to clinical
guidelines, for treatment of depression and suicidal
behaviour, was implemented and sustained over a two-
year period after an active implementation. Quality indi-
cators were helpful tools in the implementation process
as well as in the evaluation. Thus, supported local
implementation based on local organisation theory may
be a strategy for narrowing the gap between evidence-
based care and current practice.
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